LIU Pharmacy Receives $2 Million FDA Research Grant
Long Island University,
BROOKLYN, N.Y. (August 2, 2016) – The Arnold and Marie Schwartz College of Pharmacy and Health Sciences (LIU Pharmacy) has been awarded a $2 million grant from the U.S. Food and Drug Administration (FDA) for a research initiative titled “Building towards Statistically-Based Pharmaceutical Quality Standards.” The grant will be awarded over three years, and will be used to study variability in marketed pharmaceutical product.
“This grant from the FDA is a testament to the capabilities of LIU Pharmacy’s award-winning pharmaceutical scientists, led by an exceptional dean and an award-winning researcher in Dr. John Pezzuto,” said Dr. Kimberly R. Cline, president of LIU. “We look forward to using this grant to create transformational opportunities for LIU Pharmacy students to participate in FDA-sponsored research.”
The grant is focused on assessing the variability in some key non-clinical performance properties of a range of products. These properties, such as the rate at which tablets dissolve, are key to ensuring that products can be manufactured to always perform as expected.
The grant will be shared with subcontractors at the Purdue University School of Chemical Engineering, where advanced statistical analysis will be used to jointly design and guide LIU’s experiments on how products perform in the laboratory. The findings will be used to generate statistical models to help better understand the design and manufacturing control needed for new drug products.
“This grant will enable our students to work with our distinguished faculty to make impactful contributions to advance the pharmaceutical community’s body of knowledge,” said Dr. Pezzuto, a past recipient of the American Association of Colleges of Pharmacy’s prestigious Volwiler Research Award. “The research conducted with this grant will lead to more effective drugs for patients around the world.”
LIU Pharmacy is home to three state-of-the-art research institutes: the Lachman Institute for Pharmaceutical Analysis, the Joan B. and Samuel J. Williamson Institute for Pharmacometrics, and the Natoli Engineering Institute for Industrial Pharmacy Development and Research. LIU Pharmacy is also a member of the National Institute for Pharmaceutical Technology and Education, joining 15 other top schools of pharmacy from across the United States in a shared mission to improve human health by advancing quality, safety, affordability and speed to market of medicines through collaborative research.
LIU Brooklyn offers more professional programs in health care than any other campus in New York City, including nationally recognized programs in Respiratory Care and Physician Assistant Studies, in addition to the M.S., Ph.D. and Pharm.D. programs offered by LIU Pharmacy, which was founded in 1886 as New York’s first College of Pharmacy.
LIU is one of the nation’s largest private universities. Since 1926, LIU has provided high quality academic programs taught by world-class faculty. LIU offers 500 accredited programs to more than 20,000 students and has a network of over 200,000 alumni, including leaders in industries across the globe. Visit liu.edu
for more information.
Return to Press Releases